Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 8 - The Untold Story

BTCY: Initiating Coverage – Outpatient Remote Cardiac Health Monitoring & Ecosystem with Emerging Growth Company Profile

By T. Moore, CFA NASDAQ:BTCY READ THE FULL BTCY RESEARCH REPORT

Benzinga

UCASU: Diversification into agriculture properties continues

By Beth Senko, CFA OTC:UCASU READ THE FULL UCASU RESEARCH REPORT

Benzinga

SQZ: IND Cleared for Enhanced APCs

By John Vandermosten, CFA NYSE:SQZ READ THE FULL SQZ RESEARCH REPORT

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

ACHV: The Final Phase III Begins

By John Vandermosten, CFA NASDAQ:ACHV READ THE FULL ACHV RESEARCH REPORT

Benzinga

Why The Stock Market Is 'Not Out Of The Woods Yet'

Cameron Dawson, CFA and chief market strategist at Fieldpoint Private, joined Benzinga’s PreMarket Prep show Tuesday morning.

Benzinga

BIOAF: Third Quarter Results

By John Vandermosten, CFA OTC:BIOAF READ THE FULL BIOAF RESEARCH REPORT

Benzinga

BLRX: Initiating on BioLineRx: Mobilizing the Troops with Motixafortide

By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT

Benzinga

Read news from The Economist, FT, and more,
with one subscription

LGVN: Using Cellular Technology to Ease Major Medical Issues

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

DRIO: 2022 Outlook, Physimax Acquisition

By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT

Benzinga

Nation records highest death toll for the pandemic following grim two weeks of rising numbers – as it happened

This blog is now closed

The Guardian - AU

MDXG: Model Updates

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT

Benzinga

LTRN: Multiple Collaborations Illuminating Way Forward

By John Vandermosten, CFA NASDAQ:LTRN READ THE FULL LTRN RESEARCH REPORT

Benzinga

HTBX: RapidVax Unveiled; Elusys Acquisition

By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT

Benzinga

EMMA: Easing Suffering from Sickle Cell Disease

By Brad Sorensen, CFA OTC:EMMA READ THE FULL EMMA RESEARCH REPORT

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bureau of Meteorology

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.